BioNTech SE (BNTX) Inventory (2018 - 2025)

BioNTech SE (BNTX) has 8 years of Inventory data on file, last reported at $128.9 million in Q4 2025.

• For the quarter ending Q4 2025, Inventory fell 57.43% year-over-year to $128.9 million; the trailing twelve-month figure through Dec 2025 stood at $128.9 million (down 57.43% YoY), and the FY2025 full-year result was $125.1 million, down 58.69% from the prior year.
• Inventory slipped to $128.9 million in Q4 2025, from $263.9 million in the prior quarter.
• In the past five years, Inventory ranged from a high of $574.8 million in Q4 2021 to a low of $128.9 million in Q4 2025.
• A 5-year average of $360.3 million and a median of $370.7 million in 2024 frame the typical range for Inventory.
• Across the five-year window, Inventory jumped 652.16% in 2021 and tumbled 57.43% in 2025, its largest moves.
• Tracing BNTX's Inventory over 5 years: stood at $574.8 million in 2021, then dropped by 21.98% to $448.5 million in 2022, then declined by 14.19% to $384.9 million in 2023, then retreated by 21.34% to $302.7 million in 2024, then plunged by 57.43% to $128.9 million in 2025.
• Business Quant data shows BNTX's Inventory at $128.9 million in Q4 2025, $263.9 million in Q3 2025, and $261.1 million in Q2 2025.